Julia Casiday
Family · Winnsboro, LANPI 1740605484
Payments from drug & device makers
Across 61 payments — averaging $22.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$338
- Bayer$183
- Mayne Pharma Commercial LLC$176
- Lilly USA, LLC$146
- Boehringer Ingelheim$108
- Exact Sciences$96
- plus $323 from 18 others
What the payments were for
- Food & beverage$1,369100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $338 |
| Bayer | 10 | $183 |
| Mayne Pharma Commercial LLC | 2 | $176 |
| Lilly USA, LLC | 8 | $146 |
| Boehringer Ingelheim | 7 | $108 |
| Exact Sciences | 6 | $96 |
| Pfizer | 2 | $26 |
| Dexcom, Inc. | 1 | $26 |
| AbbVie | 2 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| AstraZeneca | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Corcept Therapeutics | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Smith+Nephew | 1 | $17 |
| Insulet Corporation | 1 | $15 |
| Medtronic | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Abbott | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $12 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXTSTELLIS$125
- Ozempic$125
How this compares
$1,369 in reported general payments places this provider in the 65th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $22,081 |
| MounjaroTirzepatide | 13 | $15,262 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 56 | $3,714 |
| SynthroidLevothyroxine Sodium | 13 | $626 |
| Omega-3 Acid Ethyl Esters | 15 | $406 |
| Omeprazole | 40 | $353 |
| Pravastatin Sodium | 18 | $347 |
| Diclofenac Sodium | 14 | $171 |
| Gabapentin | 26 | $154 |
| Pantoprazole Sodium | 16 | $136 |
| Amlodipine Besylate | 24 | $74 |
| Fluticasone Propionate | 16 | $69 |
| Hydrochlorothiazide | 21 | $59 |
| Metoprolol Tartrate | 12 | $50 |
| Lisinopril | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $338 | $22,08118 claims |
| Lilly USA, LLCMounjaro | $146 | $15,26213 claims |
| AbbVieSynthroid | $25 | $62613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,610 family providers in Louisiana.
Other family in Winnsboro
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.